Nanosol

Ascendia pharmaceuticals offers cGMP clinical batches of injectable dosage forms. Features: a dedicated, self-contained cleanroom for conducting sterile manufacturing and fill processes is maintained. Contact us for more information.

Ascendia pharmaceuticals offers cGMP clinical batches of tablet and capsule dosage forms. Features: it require capability to granulate, blend, and roller compact to make tablet batches for immediate release and modified release applications. Contact us for more information.

Ascendia pharmaceuticals offers emulsol. Features: it is a technology for production of oil-in-water nano-emulsions. Nano-emulsions are meta-stable, and a high level of input energy is required to produce a nano-emulsion. Contact us for more information.

Ascendia pharmaceuticals offers lyophilization. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information.

Ascendia pharmaceuticals offers micro-fluidizer. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information.

Ascendia pharmaceuticals offers nano-particle bead-milling. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information.

NanoSol is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution.  A ten-to-twenty-fold increase in surface area can result from reducing particle size from a micronized dru...

NanoSol is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution.  A ten-to-twenty-fold increase in surface area can result from reducing particle size from a micronized dru...

NanoSol is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution.  A ten-to-twenty-fold increase in surface area can result from reducing particle size from a micronized dru...

Ascendia pharmaceuticals offers nmr and xrpd. Features: it is an analytical instrument for testing pharmaceutical formulations. Contact us for more information.

Ascendia pharmaceuticals offers particle size distribution analysis. Features: it is an analytical instrument for testing pharmaceutical formulations. Contact us for more information.

Ascendia pharmaceuticals offers roller compaction. Features: it is an equipment for producing pharmaceutical formulations. Contact us for more information.

Transformative technologies and the opportunities afforded by the COVID-19 pandemic have spurred investment in the life sciences outsourcing sector, according to a panel of industry experts speaking at CPHI North America on Monday.

Pharma R&D productivity has remained stagnant in the new millennium, despite record industry growth. While new technology has improved productivity in nearly every other sector, efficiency in pharmaceutical R&D is declining (or as described by MedCity News — “broken”).What obstacles are in the way of improving productivity in the pharmaceutical industry? How can we meet these challenges? At Ascendia Pharma, we’re proud to have innovative strategies in place to help our clients get their drugs from R&D to market faster.